Beijing, China

Mengmeng Liang

This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Beijing Immunochina Pharmaceuticals Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mengmeng Liang. Retrieved from https://idiyas.com/inventor/mengmeng-liang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mengmeng Liang - Innovator in Chimeric Antigen Receptor Optimization

Introduction

Mengmeng Liang is a notable inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in the optimization of chimeric antigen receptors. His work is crucial for advancements in targeted therapies for various diseases.

Latest Patents

Mengmeng Liang holds a patent for the "Optimization of Chimeric Antigen Receptor." This innovation is pivotal in enhancing the efficacy of immunotherapies, which are increasingly important in modern medicine. He has 1 patent to his name, showcasing his commitment to advancing scientific knowledge.

Career Highlights

Currently, Mengmeng Liang is employed at Beijing Immunochina Pharmaceuticals Co., Ltd. His role at the company allows him to apply his expertise in developing innovative solutions in the pharmaceutical industry. His work is instrumental in pushing the boundaries of what is possible in medical treatments.

Collaborations

Mengmeng has collaborated with talented individuals such as Ting He and Feifei Qi. These partnerships highlight the importance of teamwork in the research and development process, fostering an environment where innovative ideas can flourish.

Conclusion

Mengmeng Liang's contributions to the field of biotechnology, particularly through his patent on chimeric antigen receptors, demonstrate his dedication to innovation. His work at Beijing Immunochina Pharmaceuticals Co., Ltd. and collaborations with other professionals further emphasize the impact of teamwork in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…